ZMZubair Mumtaz

Zubair Mumtaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zubair Mumtaz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Electrocardiographic Predictors of Concealed Left-Sided Accessory Pathways in Patients with Narrow-Complex Tachycardia: Development and Internal Validation of the CLAP Score

    by Ali Hyder, Khayyam Amer, Arzalan Baig, Reema Qayoom, Zubair Mumtaz, Muhammad Sarim Ansari, Maqsood Alam, Muhammad Mohsin, Faisal Qadir, Ghazala Irfan

    Objectives: Aim of this study was to identify electrocardiographic predictors of electrophysiological study (EPS)-confirmed concealed left-sided accessory pathways in patients with narrow-complex tachycardia and to develop and internally validate an ECG-based prediction score. Methodology: This cross-sectional diagnostic accuracy and prediction-model development study included 290 consecutive adults undergoing EPS for narrow-complex tachycardia. Twelve-lead ECGs recorded during tachycardia were independently evaluated by two electrophysiologists blinded to EPS findings. Candidate ECG predictors included RP interval, pseudo-R wave in V1, pseudo-S waves in the inferior leads, ST-segment depression, P-wave morphology, and heart rate. The primary outcome was an EPS-confirmed concealed left-sided accessory pathway. Results: Among 290 patients, 238 (82.1%) had atrioventricular nodal reentrant tachycardia (AVNRT), 29 (10.0%) had left-sided atrioventricular reentrant tachycardia (AVRT), 12 (4.1%) had right-sided AVRT, and 11 (3.8%) had non-inducible tachycardia. Absence of a pseudo-R wave in V1 was independently associated with a concealed left-sided accessory pathway (adjusted OR 16.14, 95% CI 1.95–133.27; p=0.010), as was an intermediate RP interval (>90 ms but RP < PR; adjusted OR 13.72, 95% CI 4.56–41.28; p200 beats/minute were retained in the exploratory CLAP score but did not reach statistical significance in the multivariable model. The resulting 0–6-point CLAP score assigned 2 points each for intermediate RP interval and absence of pseudo-R wave in V1 and 1 point each for ST-segment depression and heart rate >200 beats/minute. At a cutoff of ≥4, the score demonstrated 79.31% sensitivity, 88.51% specificity, 43.40% positive predictive value, and 97.47% negative predictive value. Discrimination across the complete score range was high (AUC 0.938, 95% CI 0.902–0.974), with an optimism-corrected AUC of 0.938, calibration intercept of 0.012, and calibration slope of 0.983 after bootstrap internal validation. Conclusion: Selected ECG characteristics recorded during narrow-complex tachycardia were associated with EPS-confirmed concealed left-sided accessory pathways. The preliminary CLAP score demonstrated promising discrimination and internal calibration in this single-center cohort.

  • Open Access

    Cardiac Implantable Electronic Device Procedure Trends, Clinical Indications, and In-Hospital Outcomes at a Tertiary Cardiac Center in Pakistan: A Seven-Year Registry-Based Analysis

    by Sajid Ali Shaikh, Reema Qayoom, Iram Jehan Balouch, Syed Fayaz Mujtaba, Tahreem Shafi, Muhammad Sarim Ansari, Zubair Mumtaz, Ghulam Abbas Shaikh

    Objective: This study aimed to characterize the demographic profile, procedural trends, clinical indications, immediate procedural success, and in-hospital complications of cardiac implantable electronic devices (CIEDs)-related procedures performed during a seven-year institutional experience at a tertiary care center in Sukkur, Pakistan. Methodology: This retrospective descriptive registry-based analysis included consecutive CIED-related procedures performed between June 2018 and July 2025. The procedure was defined as the unit of analysis and included primary device implantation as well as generator replacement, lead revision/readjustment, device upgrade, and device extraction/wound debridement. Of 1,825 procedural records screened, 8 (0.4%) were excluded because of missing critical information regarding the primary indication and/or procedural outcome, leaving 1,817 procedures for complete-case analysis. Data were obtained from the institutional electronic registry and associated clinical records. Results: A total of 1,817 CIED procedures were included, of which 1,001 (55.1%) were performed in male patients and 816 (44.9%) in female patients. The mean age at the time of procedure was 58.7 ± 14.5 years. Single-chamber ventricular-based pacemakers were the most frequently recorded procedure category (n=964, 53.1%), followed by dual-chamber pacemakers (n=500, 27.5%) and single-chamber ICDs (n=144, 7.9%). Symptomatic complete heart block was the predominant primary indication (n=1,245, 68.5%), followed by high-degree atrioventricular block (n=237, 13.0%). The immediate procedural success rate was 100% (1,817/1,817). In-hospital complications were recorded in 33 procedures (1.8%); lead dislodgement was the most frequent complication (n=13, 0.7%), followed by pneumothorax (n=5, 0.3%) and deep vein thrombosis (n=5, 0.3%). Cardiac perforation/tamponade and infection each occurred in 4 procedures (0.2%). Two in-hospital deaths (0.1%) were recorded, one associated with severe haemothorax and one with cardiac perforation/tamponade. Conclusion: Over seven years, single-chamber ventricular-based pacemaker procedures constituted the largest proportion of CIED interventions at this tertiary cardiac satellite center, with symptomatic complete heart block representing the predominant primary indication. Immediate procedural success was recorded in all included procedures, while in-hospital complications and mortality occurred in 1.8% and 0.1% of procedures, respectively.

  • Open Access

    Influence of Age, Gender, and Anatomical Location on Outcomes of Electrophysiology Study and Radiofrequency Catheter Ablation in Atrioventricular Reciprocating Tachycardia: A Single-Center Experience from a Tertiary Care Hospital

    by Zubair Mumtaz, Muhammad Faisal Khanzada, Reema Qayoom, Sajid Ali Shaikh, Abdul Mueed, Faisal Qadir

    Objectives: Radiofrequency catheter ablation (RFA) is an established curative intervention for the management of supraventricular tachycardias (SVTs). This study aimed to evaluate our institutional experience with RFA and electrophysiology study (EPS) in patients presenting with atrioventricular reciprocating tachycardia (AVRT), focusing on outcomes in relation to age, gender, and anatomical location of accessory pathways (APs). Methodology: A retrospective, observational study was conducted at the Cardiac Electrophysiology Department of the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Data were collected for all patients undergoing EPS and RFA for AVRT between July 2017 and July 2023. A total of 415 patients were included, of whom 188 (45.3%) were male. Results: Of the 415 patients, 214 (51.6%) exhibited manifest APs. The most frequently observed APs were located in the left lateral and right free wall regions. Among 39 (16.7%) patients with parahisian APs, only 9 ablation attempts were made due to the proximity to the conduction system, with 5 procedures resulting in successful outcomes. Orthodromic AVRT was identified in 363 patients (87.5%), antidromic AVRT in 41 (9.9%), and both forms in 11 (2.7%). Multiple APs were present in 22 patients (5.3%), and pre-excited atrial fibrillation occurred in 35 patients (8.4%). The overall short-term procedural success rate was 71.5% (n=266), including 3 partial successes. Right-sided APs were significantly more prevalent in female patients (60.8% vs. 50.5%, p=0.036), whereas left-sided APs were more common in male patients (52.1% vs. 39.2%, p=0.008). No significant association was found between patient age and procedural outcome. Conclusion: EPS followed by RFA is a safe and effective therapeutic approach for symptomatic AVRT. Our findings highlight gender-based anatomical differences and support the utility of RFA even in resource-limited settings, as demonstrated in this single-center tertiary care study.

  • Open Access

    Pharmacological Agents for Induction of Supraventricular Tachycardia during Electrophysiology Study: A Retrospective Cohort Analysis

    by Ahmed Mohammed Ahmed, Ghazala Irfan, Arshad Ali, Romana Pirah, Sarim Ansari, Faisal Qadir, Zubair Mumtaz, Reema Qayoom, Muhammad Mohsin, Azam Shafquat

    Objectives: Most supraventricular tachycardia (SVT) can be induced using standard electrophysiological pacing maneuvers, pharmacological agents are often required when tachycardia is not inducible at baseline. This study aimed to evaluate the need for pharmacological agents and to determine their success rates in inducing SVT during EPS among patients in whom tachycardia could not be induced using standard electrophysiological maneuvers. Methodology: A retrospective cohort study was conducted at the National Institute of Cardiovascular Diseases, Karachi, including patients who underwent EPS for SVT induction between 1st January 2022 and 31st December 2023. Of 1,217 EPS procedures performed, 1,201 patients were included after excluding cases with incomplete data or repeat procedures. The primary outcomes were the proportion of patients requiring pharmacological induction and the success rate of SVT induction following drug administration. Results: The mean age of the cohort was 42.9 ± 17.1 years, with a female predominance (59.4%). SVT was successfully induced using electrophysiological maneuvers alone in 939 patients (78.2%). Pharmacological agents were required in 262 patients (21.8%), with an overall induction success rate of 38.2% in this subgroup. Atropine was administered in 245 cases and successfully induced SVT in 100 patients (40.8%). Metoprolol and epinephrine did not result in successful induction. Among pharmacologically induced SVTs, atrioventricular nodal reentrant tachycardia (AVNRT) was the most common subtype. Conclusion: Most SVTs can be induced using electrophysiological maneuvers alone. In cases refractory to pacing, atropine facilitated SVT induction in a limited proportion of patients, while other agents demonstrated minimal utility.